A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
Xiaoting Wei(Peking University), Lu Si(Peking University), Xiaobiao Ma(Huazhong University of Science and Technology), Hongqi Tian(Eli Lilly (United States)), Zhengyun Zou(Nanjing University of Chinese Medicine), Meiyu Fang(Zhejiang Cancer Hospital), Ying Cheng(Jilin Province Tumor Hospital), Zhiguo Luo(Fudan University Shanghai Cancer Center), Yu Chen(Fujian Medical University), Zhongwei Jia(Peking University), Xinlan Liu(Yunnan Agricultural University), Peng Zhang(Chinese Academy of Sciences), Jing Chen(Hebei University of Economics and Business), Xiubao Ren(Tianjin Medical University Cancer Institute and Hospital), Junping Zhang(Tianjin University of Traditional Chinese Medicine), Gang Huang(Shanghai Jiao Tong University), Jiwei Liu(Northeast Normal University), Jiyan Liu(Zhejiang University), Hongming Pan, Jun Guo(Peking University), Xiaoshi Zhang(Sun Yat-sen University), Weizhen Zhang(University of Michigan–Ann Arbor), Di Wu(Foshan University), Renbing Jiang(Xinjiang Medical University)
Cited by 30
Related Papers
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Induction of Pyroptosis and Its Implications in Cancer Management
|Frontiers in Oncology|2019|274
Bone mesenchymal stem cells stimulation by magnetic nanoparticles and a static magnetic field: release of exosomal miR-1260a improves osteogenesis and angiogenesis
|Journal of Nanobiotechnology|2021|251
Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma
|Annals of Surgery|2014|229